Insulin degludec and liraglutide Subcutaneous and NovoLog Mix 70/30
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and NovoLog Mix 70/30 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Insulin degludec and liraglutide Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Insulin degludec and liraglutide Subcutaneous-NovoLog Mix 70/30 FlexPen
- Insulin degludec and liraglutide Subcutaneous-NovoLog PenFill
- Insulin degludec and liraglutide Subcutaneous-Novoseven
- Insulin degludec and liraglutide Subcutaneous-NovoSeven RT
- NovoLog Mix 70/30-Insulin degludec Subcutaneous
- NovoLog Mix 70/30-Insulin detemir
- NovoLog Mix 70/30-Insulin Detemir (Cartridges and Prefilled Syringes)
- NovoLog Mix 70/30-Insulin Detemir (Vials)
- NovoLog Mix 70/30-Insulin detemir Subcutaneous
- NovoLog Mix 70/30-Insulin glargine